financetom
Business
financetom
/
Business
/
Chevron Strikes $6.5 Billion Deal to Offload Canadian Oil Sands, Shale Assets
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chevron Strikes $6.5 Billion Deal to Offload Canadian Oil Sands, Shale Assets
Oct 7, 2024 4:43 AM

07:21 AM EDT, 10/07/2024 (MT Newswires) -- Chevron ( CVX ) is offloading some of its Canadian assets and interests as it continues plans to slim down its global energy portfolio through divestments, it said Monday.

The oil giant's subsidiary, Chevron Canada, agreed to sell its 20% non-operated interest in the Athabasca Oil Sands Project and a 70% operated interest in the Duvernay shale to Canadian Natural Resources ( CNQ ) for $6.5 billion in cash.

The effective date of the transaction for the Alberta-based assets is Sept. 1, the companies said. The deal requires approval from regulators and is anticipated to be completed in the fourth quarter.

Altogether, the assets contributed about 84,000 barrels of oil equivalent production per day in 2023, Chevron ( CVX ) said. The sale is in line with its plan to divest $10 billion to $15 billion in assets by 2028, it added.

Chevron's ( CVX ) shares were up 1.3% in premarket activity while Canadian Natural Resources' ( CNQ ) US-listed stock added 1.9%.

The deal also includes the acquisition of interests in other non-producing oil sands leases, Canadian Natural said in a separate statement. The company plans to finance the purchase through a CA$4 billion ($2.9 billion) loan with existing cash and committed bank facilities.

"These assets are a great fit for Canadian Natural and will allow us to further implement our strong operating culture and drive significant value for shareholders," President Scott Stauth said in the statement. "We expect further efficiencies and improved performance going forward."

Price: 152.50, Change: +1.76, Percent Change: +1.17

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved